TAURX THERAPEUTICS EUROPE LTD.Active

Company number SC531194Private limited companyIncorporated 2016

Key figures

£14,428+14.7%
Net assets 2023/24
+12.8%
Average annual growth 2019/20–2023/24
05 k10 k15 k2019/202020/212021/222022/232023/24

Like most small UK companies, TAURX THERAPEUTICS EUROPE LTD. does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2023/24
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
010 k20 k30 k2019/202020/212021/222022/232023/24
Filed accounts2019/20–2023/24
2019/202020/212021/222022/232023/24
Total assets200200200200200
Total liabilities9,0978,57910,78212,77914,628
Net assets / total equity8,8978,37910,58212,57914,428
Average number of employees00000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: TAURX THERAPEUTICS EUROPE LTD.

Company

TAURX THERAPEUTICS EUROPE LTD. is a private limited company registered with Companies House under company number SC531194. It was incorporated on 31 Mar 2016. Its status is active. The registered office is in Aberdeen (AB24). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).

Accounts

The latest accounts in the database are for 2023/24 (period ending 30 Jun 2024); the company files small company accounts. Net assets were £14,428, up 14.7% on the previous year. Total assets were £200 and total liabilities £14,628. The company had an average of 0 employees. Figures are available for 5 financial years (2019/20–2023/24).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 13 Apr 2027.